Delirium, Dementia, Amnestic, Cognitive Disorders  >>  neramexane (KRP-209)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
neramexane (KRP-209) / AbbVie
NCT00090116: The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

Completed
3
400
US
Neramexane
Forest Laboratories
Alzheimer's Disease
03/05
03/05

Download Options